Articles

Export this record

Export selected records

Export record to excel

File type to download

Beta version

Record title

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Record identifier

TN_cdi_proquest_journals_2244079094

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

ACCESS
https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2244079094

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Full title

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Publisher

England: Elsevier Ltd

Journal title

The Lancet (British edition), 2016, Vol.387 (10018), p.545-557

Record Identifier

TN_cdi_proquest_journals_2244079094

Language

English

Formats

Publication information

Publisher

Identifiers

PRIMARY IDENTIFIERS

Record Identifier

TN_cdi_proquest_journals_2244079094

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2244079094

OTHER IDENTIFIERS

ISSN

E-ISSN

DOI

How to access this item

Online

1 item

How to access?

Login with a Library card